The multilineage clonogenic capacity and the lack of correlation between % of blasts/CD34+ cells indicate that CFU assays with BM-derived AML cells read out normal or preleukemic HSC/progenitors rather than self-renewing clonal AML blasts. This evidence concerns the gene CD34 and acute myeloid leukemia.